首页> 美国卫生研究院文献>other >2012 David W. Robertson Award for Excellence in Medicinal Chemistry: Neoclerodanes as Atypical Opioid Receptor Ligands
【2h】

2012 David W. Robertson Award for Excellence in Medicinal Chemistry: Neoclerodanes as Atypical Opioid Receptor Ligands

机译:2012年大卫·罗伯逊(David W. Robertson)药物化学卓越奖:新环戊烷类药物作为非典型阿片受体配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The neoclerodane diterpene salvinorin A is the major active component of the hallucinogenic mint plant Salvia divinorum Epling & Játiva (Lamiaceae). Since the finding that salvinorin A exerts its potent psychotropic actions through the activation of opioid receptors, the site of action of morphine and related analogues, there has been much interest in elucidating the underlying mechanisms behind its effects. These effects are particularly remarkable, because (1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist, and (2) its effects are not mediated through the previously investigated targets of psychotomimetics. This perspective outlines our research program, illustrating a new direction to the development of tools to further elucidate the biological mechanisms of drug tolerance and dependence. The information gained from these efforts is expected to facilitate the design of novel agents to treat pain, drug abuse, and other CNS disorders.
机译:新环戊烷二萜Salvinorin A是致幻薄荷植物Salvia divinorum Epling&Játiva(唇形科)的主要活性成分。自从发现Salvinorin A通过激活阿片样物质受体,吗啡及相关类似物的作用部位发挥其有效的精神作用以来,人们一直对阐明其作用背后的潜在机制感兴趣。这些作用特别显着,因为(1)沙威诺林A是第一个报道的非氮类阿片受体激动剂,并且(2)其作用不受先前研究的拟精神病药物靶标介导。这种观点概述了我们的研究计划,阐明了进一步阐明药物耐受性和依赖性生物学机制的工具开发的新方向。从这些努力中获得的信息有望促进新型药物的设计,以治疗疼痛,药物滥用和其他中枢神经系统疾病。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号